This topic contains a solution. Click here to go to the answer

Author Question: A patient who is taking a fluoroquinolone antibiotic for pyelonephritis develops Clostridium ... (Read 60 times)

Bernana

  • Hero Member
  • *****
  • Posts: 530
A patient who is taking a fluoroquinolone antibiotic for pyelonephritis develops Clostridium difficileassociated disease (CDAD). The primary care NP should treat for C. difficile and _____ fluoroquinolone.
 
  a. continue the
  b. discontinue the
  c. increase the dose of
  d. decrease the dose of

Question 2

A patient who has symptoms of depression also reports chronic pain. The primary care NP should begin therapy with:
 
  a. fluoxetine (Prozac).
  b. duloxetine (Cymbalta).
  c. bupropion (Wellbutrin).
  d. nortriptyline (Pamelor).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

guyanai

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

B
Patients who develop CDAD while taking fluoroquinolones should stop taking the drug immediately

Answer to Question 2

B
Duloxetine is an antidepressant that also has uses for pain syndromes associated with depression.




Bernana

  • Member
  • Posts: 530
Reply 2 on: Jul 24, 2018
Gracias!


amit

  • Member
  • Posts: 364
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

For a complete list of videos, visit our video library